Pevsner Alex, Nehmeh Sadek A, Humm John L, Mageras Gig S, Erdi Yusuf E
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
Med Phys. 2005 Jul;32(7Part1):2358-2362. doi: 10.1118/1.1943809.
Respiratory motion is known to affect the quantitation of FDG18 uptake in lung lesions. The aim of the study was to investigate the magnitude of errors in tracer activity determination due to motion, and its dependence upon CT attenuation at different phases of the motion cycle. To estimate these errors we have compared maximum activity concentrations determined from PET/CT images of a lung phantom at rest and under simulated respiratory motion. The NEMA 2001 IEC body phantom, containing six hollow spheres with diameters 37, 28, 22, 17, 13, and 10 mm, was used in this study. To mimic lung tissue density, the phantom (excluding spheres) was filled with low density polystyrene beads and water. The phantom spheres were filled with FDG18 solution setting the target-to-background activity concentration ratio at 8:1. PET/CT data were acquired with the phantom at rest, and while it was undergoing periodic motion along the longitudinal axis of the scanner with a range of displacement being 2 cm, and a period of 5 s. The phantom at rest and in motion was scanned using manufacturer provided standard helical/clinical protocol, a helical CT scan followed by a PET emission scan. The moving phantom was also scanned using a 4D-CT protocol that provides volume image sets at different phases of the motion cycle. To estimate the effect of motion on quantitation of activities in six spheres, we have examined the activity concentration data for (a) the stationary phantom, (b) the phantom undergoing simulated respiratory motion, and (c) a moving phantom acquired with PET/4D-CT protocol in which attenuation correction was performed with CT images acquired at different phases of motion cycle. The data for the phantom at rest and in motion acquired with the standard helical/clinical protocol showed that the activity concentration in the spheres can be underestimated by as much as 75%, depending on the sphere diameter. We have also demonstrated that fluctuations in sphere's activity concentration from one PET/CT scan to another acquired with standard helical/clinical protocol can arise as a consequence of spatial mismatch between the sphere's location in PET emission and the CT data.
众所周知,呼吸运动会影响肺部病变中18F-FDG摄取的定量分析。本研究的目的是调查由于运动导致的示踪剂活性测定误差的大小,以及其在运动周期不同阶段对CT衰减的依赖性。为了估计这些误差,我们比较了在静止状态和模拟呼吸运动下肺部模型的PET/CT图像所确定的最大活性浓度。本研究使用了NEMA 2001 IEC体模,其包含六个直径分别为37、28、22、17、13和10毫米的空心球体。为模拟肺组织密度,体模(不包括球体)填充有低密度聚苯乙烯珠和水。体模球体填充有18F-FDG溶液,使靶与本底活性浓度比为8:1。在体模静止时以及沿扫描仪纵轴进行周期性运动(位移范围为2厘米,周期为5秒)时采集PET/CT数据。使用制造商提供的标准螺旋/临床方案对静止和运动状态下的体模进行扫描,即先进行螺旋CT扫描,然后进行PET发射扫描。还使用4D-CT方案对运动体模进行扫描,该方案可在运动周期的不同阶段提供容积图像集。为了估计运动对六个球体中活性定量分析的影响,我们检查了以下情况的活性浓度数据:(a)静止体模,(b)进行模拟呼吸运动的体模,以及(c)采用PET/4D-CT方案采集的运动体模,其中使用在运动周期不同阶段采集的CT图像进行衰减校正。使用标准螺旋/临床方案采集的静止和运动体模的数据表明,根据球体直径不同,球体中的活性浓度可能被低估多达75%。我们还证明,由于PET发射中球体位置与CT数据之间的空间不匹配,使用标准螺旋/临床方案从一次PET/CT扫描到另一次扫描时,球体活性浓度会出现波动。